Genomic complexity is associated with epigenetic regulator mutations and poor prognosis in diffuse large B-cell lymphoma
Hua You(Soochow University), Ken H. Young(Duke Medical Center), Michael Møller(Hospital South West Jutland), Karen Dybkær(Aalborg University Hospital), Govind Bhagat(Columbia University Irving Medical Center), Benjamin M. Parsons(Gundersen Health System), Maurilio Ponzoni(San Raffaele University of Rome), Bing Xu(First Affiliated Hospital of Xiamen University), Feng Zhu(Xuzhou Medical College), Eric D. Hsi(Mayo Clinic), J. Han van Krieken(Radboud University Nijmegen), Zijun Y. Xu‐Monette(Duke University), Alexandar Tzankov(University of Basel), Carlo Visco(University of Verona), Máté Nagy(NeoGenomics (United States)), April Chiu(Mayo Clinic), Youli Zu(Methodist Hospital), Maher Albitar(Center for Genomic Science), Wayne Tam(Cornell University), Qingyan Au(NeoGenomics (United States)), Miguel Á. Piris(Hospital Universitario Fundación Jiménez Díaz), Xiaosheng Fang(Shandong Provincial Hospital), Harry Nunns(NeoGenomics (United States)), Andrés J.M. Ferreri(Vita-Salute San Raffaele University), Jooryung Huh(Asan Medical Center), Wei Li(Duke Medical Center), Jane N. Winter(Northwestern University), Yong Li(Baylor College of Medicine), Fredrick B. Hagemeister(The University of Texas MD Anderson Cancer Center)
Cited by 12
Related Papers
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
|The Lancet Oncology|2018|2.5k
Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
|Nature|2011|1.5k
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
Circular RNAs function as ceRNAs to regulate and control human cancer progression
|Molecular Cancer|2018|1.1k